# Novel ECCO2R Device for Hypercapnic Respiratory Failure

> **NCT05316532** · — · UNKNOWN · sponsor: **University of Zurich** · enrollment: 60 (estimated)

## Conditions studied

- Hypercapnic Respiratory Failure

## Interventions

- **DEVICE:** Prismalung + treatment

## Key facts

- **NCT ID:** NCT05316532
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-06-05
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-12-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05316532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05316532, "Novel ECCO2R Device for Hypercapnic Respiratory Failure". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05316532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*